Results 71 to 80 of about 5,801,283 (182)

The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study

open access: yes, 2020
OBJECTIVE: Hepatocellular carcinoma (HCC) is a primary liver tumor derived from metabolic or viral chronic hepatitis, with few treatment options in advanced cases. New biomarkers that allow improving diagnosis and staging are widely desired. Here, we aim
DI GIACINTO F.   +13 more
core   +1 more source

PIVKA-II level is correlated to development of portal vein tumor thrombus in patients with HBV-related hepatocellular carcinoma

open access: yesInfectious Agents and Cancer, 2019
Aim To evaluate the correlation of serum PIVKA-II levels and development of portal vein tumor thrombus (PVTT) in hepatocellular carcinoma (HCC) patients.
Tao Li   +10 more
doaj   +1 more source

Prognostic Impact of Arterial Phase Hyperenhancement After Proton Beam Therapy for Untreated Solitary Hepatocellular Carcinoma

open access: yesCancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Purpose To evaluate the significance of persistent arterial‐phase hyperenhancement (APHE) on contrast‐enhanced CT/MRI at 6 and 12 months after proton beam therapy (PBT) for hepatocellular carcinoma (HCC). Methods We retrospectively analyzed 108 patients with solitary HCC without vascular invasion who underwent definitive PBT as initial ...
Hikaru Niitsu   +16 more
wiley   +1 more source

Oncocytoma Arising From an Accessory Adrenal Gland: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 5, September 2026.
ABSTRACT Introduction Accessory adrenal oncocytomas are rare. Consequently, the clinical characteristics and management of this entity remain poorly defined. Case Presentation A 65‐year‐old man presented with a retroperitoneal mass. Imaging revealed a 103 × 96 mm tumor adjacent to the left kidney.
Yuki Seki   +9 more
wiley   +1 more source

PIVKA‑II is associated with liver function, bone metabolism, and muscle function in patients with liver disease. [PDF]

open access: yesBiomed Rep
Protein induced by vitamin K (VK) absence‑II (PIVKA‑II) is a sensitive marker for diagnosing hepatoma but is occasionally detected in patients without hepatoma Here, the clinical significance of serum PIVKA‑II levels in patients who were not administered
Honda T   +13 more
europepmc   +3 more sources

Oxylipins‐Omics Combine With Single‐Molecule Analysis Identifies 13(S)‐HODE Positive Extracellular Vesicles as a Diagnostic Biomarker for AFP‐Negative Hepatocellular Carcinoma

open access: yesJournal of Extracellular Vesicles, Volume 15, Issue 9, September 2026.
Our work identifies EV‐derived 13(S)‐HODE as a novel biomarker for HCC, establishes a single‐molecule platform for EV lipid analysis, and constructs a high‐performance diagnostic model by integrating multi‐dimensional data, offering new potential strategies for early monitoring and precise diagnosis of HCC.2 ABSTRACT Efficient diagnostic biomarkers ...
Yu Wang   +15 more
wiley   +1 more source

Validation of a novel model for the early detection of hepatocellular carcinoma

open access: yesClinical Proteomics, 2019
Background The biomarkers alpha-fetoprotein (AFP) and protein induced by vitamin K absence/antagonist-II (PIVKA-II) may be useful for detecting early-stage hepatocellular carcinoma (HCC). We evaluated the performance of AFP and PIVKA-II levels, alone and
Philip M. Hemken   +11 more
doaj   +1 more source

A Novel Diagnostic Approach for Hepatocellular Carcinoma Using Glycosylated Ferritin

open access: yesHepatology Research, Volume 56, Issue 9, Page 1319-1330, September 2026.
The percentage of glycosylated ferritin relative to total ferritin (%GF) is a novel biomarker for hepatocellular carcinoma (HCC), showing diagnostic performance comparable to that of AFP and DCP. We developed the GFAD index by integrating age, sex, %GF, AFP, and DCP, achieving improved diagnostic accuracy with high sensitivity and specificity. ABSTRACT
Akiyo Ishiguro   +11 more
wiley   +1 more source

The Malaysian Society of Gastroenterology and Hepatology Consensus Statements on Prevention and Early Detection of Hepatocellular Carcinoma in Malaysia

open access: yesJournal of Gastroenterology and Hepatology, Volume 41, Issue 9, Page 2639-2655, September 2026.
ABSTRACT Background Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer‐related deaths in Malaysia. Early detection increases the likelihood of curative treatment and improves survival. This consensus document aims to provide evidence‐based, locally relevant recommendations for the prevention and early detection of HCC.
Su Yin Lau   +18 more
wiley   +1 more source

Protein Induced by Vitamin K Absence II (PIVKA-II) as a potential serological biomarker in pancreatic cancer: a pilot study [PDF]

open access: yes, 2019
Introduction: Protein induced by vitamin K absence II (PIVKA-II) is an abnormal prothrombin increased in gastrointestinal malignancy. We aimed to evaluate PIVKA-II in comparison to established pancreatic cancer (PC) biomarkers (CA 19-9, carcinoembryonic ...
Granato, Teresa   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy